The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair–proficient (MMR-P) recurrent or persistent endometrial cancer (EC).
 
Elizabeth Katherine Lee
Consulting or Advisory Role - AADi
Research Funding - AADi (Inst); KSQ Therapeutics (Inst); Merck (Inst); Repare Therapeutics (Inst); Seagen (Inst)
 
Niya Xiong
No Relationships to Disclose
 
SuChun Cheng
No Relationships to Disclose
 
Madeline Polak
No Relationships to Disclose
 
Carolyn N. Krasner
Research Funding - Cerulean Pharma
 
Susana M. Campos
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Merck; Novartis
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline
 
Alexi A. Wright
Consulting or Advisory Role - Cancer Support Community; GlaxoSmithKline; Merck
Research Funding - NCCN/AstraZeneca (Inst); Pack Health (Inst)
 
Joyce F. Liu
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Eisai; Genentech/Roche; GlaxoSmithKline; Regeneron
Research Funding - 2X Oncology (Inst); Acetylon Pharmaceuticals (Inst); Agenus (Inst); Aravive (Inst); Arch Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); IMPAC Medical Systems (Inst); Regeneron (Inst); Vigeo Therapeutics (Inst); Zentalis (Inst)
 
Meghan Shea
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); Lilly (Inst); Pfizer (Inst); Tesaro/GSK (Inst)
 
Oladapo O. Yeku
Stock and Other Ownership Interests - hC Bioscience
Honoraria - Medscape
Consulting or Advisory Role - Gimv; hC Bioscience; TigaTx
Patents, Royalties, Other Intellectual Property - Dr. Yeku has a patent for MUC16 Directed Antibodies for therapeutic applications pending and a patent for Human Artificial Chromosomes for therapeutic applications pending.
 
Cesar Martin Castro
Consulting or Advisory Role - Advanced Medical; InfiniteMD; Qiagen
Patents, Royalties, Other Intellectual Property - Co-inventor: Holographic diagnostic profiling; Co-inventor: Nanoplasmonic exosome profiling
 
Rebecca L Porter
Honoraria - OncLive Clinical Congress Consultants
 
Elizabeth Stover
Patents, Royalties, Other Intellectual Property - Patent pending
 
Sara Bouberhan
Consulting or Advisory Role - Immunogen
 
John William Moroney
No Relationships to Disclose
 
Richard T. Penson
Honoraria - AstraZeneca; Genentech/Roche; GlaxoSmithKline; Immunogen; Merck; Mersana; Novocure; Sutro Biopharma; Vascular Biogenics
Consulting or Advisory Role - AstraZeneca; Care4ward; Genentech; GlaxoSmithKline; Immunogen; Merck; Mersana; Novocure; Sutro Biopharma; Vascular Biogenics
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Cerulean Pharma (Inst); Eisai (Inst); Genentech (Inst); Regeneron (Inst); Sanofi (Inst); Tesaro (Inst); Vascular Biogenics (Inst)
Patents, Royalties, Other Intellectual Property - Blackwell Publishing; BMJ; UpToDate
Other Relationship - AstraZeneca; Roche
 
Gini F. Fleming
Honoraria - Physicans' Education Resource
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Celldex (Inst); Compugen (Inst); Compugen (Inst); Corcept Therapeutics (Inst); CytomX Therapeutics (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); K-Group Beta (Inst); Merck (Inst); Molecular Templates (Inst); P{fizer (Inst); Pfizer (Inst); Plexxikon (Inst); Roche (Inst); Sermonix Pharmaceuticals (Inst); Syros Pharmaceuticals (Inst)
Other Relationship - AstraZeneca (Inst); Caris Life Sciences (Inst); DSI (Inst); Eisai (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Abbvie
 
Ursula A. Matulonis
Honoraria - Advaxis; Alkermes; Symphogen
Consulting or Advisory Role - 2X Oncology; Agenus; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; GlaxoSmithKline; Immunogen; Merck; NextCure; Novartis; Trillium Therapeutics
Research Funding - Fujifilm; Immunogen; Leap Therapeutics; Merck; Mersana; Novartis; SQZ Biotech; Syndax; Tesaro
Travel, Accommodations, Expenses - AstraZeneca
 
Panagiotis A. Konstantinopoulos
Consulting or Advisory Role - AADi; Alkermes; Artios; AstraZeneca; Bayer; Kadmon; Merck; Mersana; Novartis; Pfizer/EMD Serono; Repare Therapeutics; Tesaro; Vertex
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb/Sanofi (Inst); Lilly (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); tesaro (Inst)